First shot fired! You turds are on notice now and have a mere 36 months of patent protection with Revlimid - the most expensive blot clot on earth. Couldn't happen to a nicer team of morons.
There are probably several generic firms that are going to challenge the patent. And Abraxis and Glouster were such fine purchases. Wall Street reacted in a negative fashion.
36 months is great. With all the downsizing and layoffs, I'd take 36 month guarantee any day. Its like buying a huge appliance and financing it with no interest for 3 years. this is good news.
ABX is off patent in 2013-2014. Management wants you to think otherwise. Vid might as well be off. Rev in a couple years. I do fear layoffs.
